TenEdge is a venture capital firm committed to identifying and investing in entrepreneurs with a strong edge in technology, innovation, and leadership, particularly within the biotech and pharmaceutical sectors. Focused on early-stage investments, TenEdge provides capital and strategic support during seed, angel, and Series A funding rounds.
Leveraging deep industry expertise, TenEdge nurtures groundbreaking companies with the potential to revolutionize healthcare and improve patient outcomes. We ensure these ventures have the leadership and resources needed to thrive in a competitive landscape.
Our portfolio includes biotechs and CRO/CDMOs with a clear edge in various areas, such as ADCs, small molecules, peptides, AI drug discovery, LNP delivery systems, and biologics CDMOs. Notable portfolio companies include Lynctech, Convergen Pharmaceuticals, Scindy Pharmaceutical, Divamics Inc., BioInno Bioscience, and Frontida Biopharma.
Company Details
- Founded
- 2018
- Address
- 2005 Eastpark Blvd, Cranbury,new Jersey 08512,united States
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Keywords
- Seed Investment, ADC, LNP delivery system, AI drug discovery, molecular glue, protein degrader, small molecule, biologics CDMO, Angel Investment, Series A, Biotech VC.
- HQ
- Cranbury, New Jersey
Tenedge Questions
Tenedge's LinkedIn profile is https://www.linkedin.com/company/tenedge
Tenedge's industry is
Venture Capital and Private Equity Principals
Tenedge's top competitors are
Bailey Station Capital,
Eisai Innovation Inc,
Enauto Ventures,
Annex Ventures,
Medtech Ventures,
Sealden Group Llc,
Goldd Global Consulting,
Forenoon Ventures, Llc,
Vye Ventures,
Founders Corner Vc.
Tenedge's categories are Venture Capital and Private Equity Principals
Tenedge's founding year is 2018
